The temporal relationship between rotateq immunization and intussusception adverse events in the vaccine adverse event reporting system (VAERS)

Medical Science Monitor

Volumn 18, Issue 2, 2012, Pages

  Geier, David A ^a,b   King, Paul G ^b   Sykes, Lisa K ^b   Geier, Mark R ^a  

^a Institute of Chronic Illnesses Inc   (United States)

^b Department of Research   (United States)

Author keywords

Intussusception; Post marketing surveillance; Rotavirus; Timing; Vaccine

Indexed keywords

ROTAVIRUS VACCINE;

ARTICLE; DISABILITY; DRUG MONITORING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FEMALE; HOSPITALIZATION; HUMAN; IMMUNIZATION; INTUSSUSCEPTION; MAJOR CLINICAL STUDY; MALE; PERMANENT DISABILITY; TREATMENT OUTCOME;

EID: 84857025663     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.882470     Document Type: Article

References (9)

1. Centers for Disease Control and Prevention: Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep, 2006; 55(RR12): 1-13
2. Verstraeten T, Baughman AL, Cadwell B et al: Enhancing vaccine safety surveillance: a capture-recapture analysis of intussusception after ro-tavirus vaccination. Am J Epidemiol, 2001;154: 1006-12
3. Vesikari T, Matson DO, Dennehy P et al: Safety and effcacy of a pen-tavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med, 2006; 354: 23-33
4. http://www.fda.gov/cber/safety/phnrota021307.htm [last accessed October 14, 2007]
5. Geier DA, King PG, Sykes LK, Geier MR: RotaTeq vaccine adverse events and policy considerations. Med Sci Monit, 2008; 14(3): PH9-16
6. Singleton JA, Lloyd JC, Mootrey GT et al: An overview of the Vaccine Adverse Event Reporting System (VAERS) as a surveillance system. VAERS Working Group. Vaccine, 1999; 17: 2908-17
7. Geier DA, Geier MR: A review of the Vaccine Adverse Event Reporting System database. Expert Opin Pharmacother, 2004; 5: 691-98
8. Haber P, Patel M, Izurieta HS et al: Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006 to September 25, 2007. Pediatrics, 2008; 121: 1206-12
9. Belongia EA, Irving SA, Shui M et al: Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine. Pediatr Infect Dis J, 2010; 29: 1-5